Impact of Various Front-line Hypertensive medication on Blood Pressure Control During Maximum Exercise Testing in Coronary Artery Disease Patients

Year : 2024 | Volume : | : | Page : –
By

Khyati Shah,

Anilkumar Mishra,

  1. Assistant Professor Shrimad Rajchandra College of Physiotherapy Gujarat India
  2. Professor Shrimad Rajchandra College of Physiotherapy Gujarat India

Abstract

It has long been known that blood pressure (BP) and cardiovascular morbidity are related. It is acknowledged that blood pressure during activity may serve as a more reliable indicator than resting blood pressure, which might not accurately reflect blood pressure at other times. Goals: 1) To assess how blood pressure behaves during physical activity in individuals with coronary artery disease (CAD) whose hypertension is managed with first-line antihypertensive medications. 2) To determine whether there were any variations in the front-line medication groups for the treatment of hypertension with respect to the ability of the medications to regulate blood pressure during physical exercise in patients with CAD. Methods: We retrospectively identified 49 CAD patients with hypertension (30 Males & 19 Females) from 68 stress tests.The patient was receiving pharmaceutical monotherapy, with an age of 52±10 years and a normal range rest arterial pressure (≤ 140/90 mmHg). Thirteen were on angiotensin converting enzyme inhibitors, ten on diuretics, twelve on calcium antagonists, and fourteen on beta blockers. Any of the following criteria, when present, led to the diagnosis of abnormal exercise behavior of blood pressure: peak systolic pressure exceeding 220 mmHg, systolic pressure rising by at least 10 mmHg/MET, or diastolic pressure increasing by at least 15 mmHg. Results: In 50% of CAD patients, beta blockers were the best treatment for physiologic response of arterial blood pressure (p<0.05), followed by calcium antagonists (36%), diuretics (31%), and angiotensin converting enzyme inhibitors (20%), which were the worst treatment for physiologic response (p<0.05).In conclusion, beta-blockers were the most effective medication in regulating blood pressure during exercise, whereas angiotensin converting enzyme inhibitors were the least effective. Calcium antagonists, diuretics, and beta-blockers were the least effective.

Keywords: stress test, arterial hypertension, Front-line anti hypertensive drugs, CAD.

How to cite this article: Khyati Shah, Anilkumar Mishra. Impact of Various Front-line Hypertensive medication on Blood Pressure Control During Maximum Exercise Testing in Coronary Artery Disease Patients. Research & Reviews: A Journal of Pharmacology. 2024; ():-.
How to cite this URL: Khyati Shah, Anilkumar Mishra. Impact of Various Front-line Hypertensive medication on Blood Pressure Control During Maximum Exercise Testing in Coronary Artery Disease Patients. Research & Reviews: A Journal of Pharmacology. 2024; ():-. Available from: https://journals.stmjournals.com/rrjop/article=2024/view=161232



References

  1. Hackam DG, Dasgupta K, Daskalopoulou SS, Quinn RR, Ravani P, Rabi DM, et al. The 2013 Canadian Hypertension Education Program’s guidelines for measuring blood pressure, diagnosing conditions, determining risk, treating hypertension, and preventing it. Epub 2013 Mar 29. Can J Cardiol. 2013;29(5):528–42.
  2. Fagard RH. Management of hypertensive cardiovascular disease with exercise treatment.2011;53(6):404–11. Prog Cardiovasc Dis.
  3. Fagard RH, Cornelissen VA. Exercise’s impact on hypertension patients’ ability to control their blood pressure.2007;14(1):12–7; Eur J Cardiovasc Prev Rehabil.
  4. LaMonte, M.J., Gray, S.L., Aragaki, A.K., et al., 2012. Angiotensin-converting enzyme inhibitors, statins, and older women’s physical performance. Joint American Geriatric Society 60, 2206–2214.
  5. Sumukadas, D., Miller, S., Band, M., and others, 2014. Do ACE inhibitors help older persons with functional impairments respond better to exercise training? a controlled, randomised experiment. A Biol. Sci. Med. Sci. J. Gerontol. 69, 736–743.
  6. Intra-arterial blood pressure response in hypertensive subjects during low- and high-intensity resistance exercise: Nery SS, Gomides RS, da Silva GV, Forjaz CLM, Mion D, Tinucci T. 2010;65(3):271-277 in Clinics.
  7. Leticia A, de Souza C, Ferreira S, Corso SD, Soares CLR, Battagin AM, et al. Pressure Reaction following Resistance Training for Various Body Parts in Hypertensive Individuals. 2010;95(3); Arq Bras Cardiol. 405–411.
  8. Miguel FM, de Souza NMF, Grings LA, Pereira GB, Leite RD, Vieira A, et al. Cardiovascular reactions to a resistance training exercise varied between normotensive and hypertensive women receiving propranolol. 2012;2012:913271; Scientific World Journal.
  9. Barros S, Ortega KC, Queiroz ACC, Costa L a. R, Souza DR, Gomides RS, and others. When hypertensive people engage in dynamic resistance exercise, amlodipine lowers blood pressure. 2015;25(1):53–60; Scand J Med Sci Sports.
  10. Aronow WS, Carey RM, Casey Jr. DE, Himmelfarb CD, Walton PK, Collins KJ, et al. 2017 An Executive Summary of ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guidelines for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults A Report on Clinical Practice Guidelines from the American Heart Association/American College of Cardiology Task Force. elevated blood pressure In 1979, Dallas, Texas; 71(6): 1269–1324, 2018
  11. Arnett DK, Hahn EJ, Buroker AB, Goldberger ZD, Albert MA, Blumenthal RS, et al. Executive Summary of the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report on Clinical Practice Guidelines from the American College of Cardiology/American Heart Association Task Force. In 2019, J Am Coll Cardiol, 74(10), 1376–1414.
  12. Williams B, Burnier M, Azizi M, Mancia G, Spiering W, Rosei EA, et al. The 2018 ESC/ESH Guidelines for the treatment of high blood pressure. 2018;39(33):3021-3104; Eur Heart J.Cardoso CG, Jr., da Silveira Lobo F, Tinucci T, Queiroz AC, Pinto LG, Gomides RS, et al. Effects of resistance and aerobic training on ambulatory blood pressure, both acute and long-term.Brazilian Clinics 2010;65(3): 317–325.
  13. Cooke G.A., Tan L.B., Wright D.J., and Williams S.G. Disparate findings of ACE inhibitor dosage on exercise capacity in heart failure: a reassessment of vasodilator therapy and study design.2001;77:239–245. Int. J. Cardiol.
  14. Onder G., Balkrishnan R., Penninx B.W. An observational study examined the association between older women’s use of angiotensin-converting enzyme medications and their physical function and muscle strength.2002;359:926–930 in The Lancet.
  15. Leahy J, Morrissey EC, Noone C, et al.A network meta-analysis comparing the effectiveness of anti-hypertensive pharmaceutical therapies versus physical activity in lowering blood pressure in individuals with hypertension.2020;27:247–55; Eur J Prev Cardiol.
  16. Dias S, Salcher-Konrad M, Nicaci H, et al.What is the difference between antihypertensive drugs and exercise therapy? 391 randomised controlled trials were included in a network meta-analysis to evaluate the effects of medication and exercise on systolic blood pressure.2019;53:859–69; Br J Sports Med.
  17. Joseph G, Torp-Pedersen C, Marott JL, et al.Dose-response relationship between physical activity level and death in individuals with normal, high, and raised blood pressure.In 2019 Hypertension 74:1307–15.
  18. Di Mascio R, Esposito AL, Di Tommaso R, Lapenna D, Ballone E, Cuccurullo F, Mezzetti A, Pierdomenico SD, Di Carlo S, and Esposito D. Cardiovascular risk with blood pressure variability in patients with controlled hypertension.2006;19:991–997 in Am J Hypertens.
  19. Eto M, Toba K, Kozaki K, Watanabe T, Kim S, Iijima K, Sudoh N, Yoshizumi M, Ako J, and Ouchi Y. Effect of fluctuation in blood pressure on cardiovascular events in older hypertensive patients.(2005) Hypertens Res. 28:1–7.
  20. Mancia G, Omboni S, Baurecht H, Hennig M, Zanchetti A, Parati G, Bilo G, Maronati A. Clinic and ambulatory blood pressure data from the European Lacidipine Study on Atherosclerosis are used to evaluate long-term antihypertensive medication.2007;25:1087–1094. J Hypertens.

 

 


Ahead of Print Subscription Original Research
Volume
Received June 24, 2024
Accepted July 22, 2024
Published August 5, 2024

Check Our other Platform for Workshops in the field of AI, Biotechnology & Nanotechnology.
Check Out Platform for Webinars in the field of AI, Biotech. & Nanotech.